Literature DB >> 2081500

Efficacy and safety of nabumetone in 5,421 patients with osteoarthritis of the hip and/or knee joints. A subgroup evaluation of an outpatient study involving 18,047 patients.

M Fedder1, I Stroehmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2081500     DOI： 10.2165/00003495-199000405-00019

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  [Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].

Authors:  E M Lemmel; I Stroehmann
Journal:  Fortschr Med       Date:  1988-04-20

2.  Safety evaluation of nabumetone in United States clinical trials.

Authors:  R E Jackson; F N Mitchell; D A Brindley
Journal:  Am J Med       Date:  1987-10-30       Impact factor: 4.965

3.  Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Nabumetone versus naproxen double-blind parallel study.

Authors:  F B Vasey; B F Germain; L R Espinoza; P Box; B I Bockow; J A Lipani; B J Mullen; A L Brodsky; R M Fleischmann; R A Fogari
Journal:  Am J Med       Date:  1987-10-30       Impact factor: 4.965

4.  Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin.

Authors:  G C Bernhard; D J Appelrouth; A D Bankhurst; J Biundo; B I Bockow; R D Brobyn; A L Brodsky; F X Burch; R W Chang; M H Cohen
Journal:  Am J Med       Date:  1987-10-30       Impact factor: 4.965
  4 in total
  1 in total

1.  Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.

Authors:  H A Friedel; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.